News Articles Tagged: Clinical Progress

The Promise of SMN-C3: A Novel SMN2 Modulator from NINGBO INNO PHARMCHEM CO.,LTD.

NINGBO INNO PHARMCHEM CO.,LTD. introduces SMN-C3, a novel SMN2 modulator with promising potential for Spinal Muscular Atrophy (SMA) treatment.

SMN-C3: A Closer Look at its Role in Spinal Muscular Atrophy Therapeutic Strategies

NINGBO INNO PHARMCHEM CO.,LTD. provides an in-depth look at SMN-C3 and its crucial role in developing new therapeutic strategies for Spinal Muscular Atrophy (SMA).